Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19

NCT04376814 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

COVID-19
Favipiravir
Kaletra
Hydroxychloroquine
Lopinavir/Ritonavir

Interventions

DRUG: Favipiravir
DRUG: Hydroxychloroquine
DRUG: Lopinavir / Ritonavir

Sponsor

Baqiyatallah Medical Sciences University